Product Name: GLUCOVANCE®
Active Ingredients:

• Metformin
• Glibenclamide (also known as glyburide)

Manufacturer: Merck KGaA
Presentation: Box containing 60 film-coated tablets.

Product Description

GLUCOVANCE® is a combination oral antidiabetic medication containing metformin and glibenclamide (glyburide). It is used in the management of type 2 diabetes mellitus when diet, exercise, and monotherapy do not provide adequate blood glucose control.

Packaging Appearance

• Branded GLUCOVANCE® pharmaceutical carton.
• Product strength varies by market (e.g., combinations such as 500 mg/2.5 mg or 500 mg/5 mg).
• Front panel typically displays:
  • GLUCOVANCE®
  • Active ingredient strengths
  • 60 tablets
• Tablets are film-coated and intended for oral administration.

Pack Contents

• 60 × film-coated tablets
• Combination of metformin hydrochloride and glibenclamide
• Oral administration

Administration

• Taken orally with meals as prescribed by a healthcare professional.
• Dosage depends on the patient’s treatment regimen and blood glucose control requirements.

Storage

• Store at room temperature in the original packaging.
• Protect from moisture and excessive heat.
• Keep out of reach of children.

Catalog Alt Text

“GLUCOVANCE® by Merck, box containing 60 film-coated tablets combining metformin and glibenclamide for oral treatment of type 2 diabetes mellitus.”